Skip to content

Creatine Effect on Brown Adipose Tissue Activation

Creatine Monohydrate Supplementation in Young, Healthy Vegetarian Adults and Its Effect on Brown Adipose Tissue Activation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04086381
Acronym
CreaBAT
Enrollment
14
Registered
2019-09-11
Start date
2018-05-01
Completion date
2020-01-22
Last updated
2021-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brown Adipose Tissue Activation, Diet-induced Thermogenesis

Keywords

Brown adipose tissue, Creatine monohydrate, Diet-induced thermogenesis

Brief summary

Pre-clinical studies indicate that creatine may play a substantial role in diet-induced thermogenesis and may have a profound effect on energy balance. A recent retrospective study of BAT activation on PET-CT scans in humans showed a positive association with the estimated renal creatinine clearance and BAT activation, possibly linking creatine metabolism in humans to BAT activity. In humans, so far little options are available to activate brown adipose tissue. The most potent intervention to activate BAT is via cold, which has previously been shown to have metabolic effects in humans. Provided the potential health benefits of brown adipose tissue activation in humans, and provided the role of brown fat in diet induced thermogenesis, we here aim to determine whether creatine monohydrate supplementation can increase diet-induced thermogenesis and activate brown adipose tissue in humans.

Interventions

DIETARY_SUPPLEMENTCreatine monohydrate

5 grams of creatine monohydrate, four times daily, for 9 consecutive days.

DIETARY_SUPPLEMENTplacebo cellulose

oral ingestion of placebo containing 20 gram cellulose daily

Sponsors

Maastricht University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Intervention model description

A double-blind, randomised, controlled, cross-over intervention trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female; * 18 to 30 years of age; * Consuming a vegetarian diet; * BMI 20-25 kg/m2.

Exclusion criteria

* Not meeting all inclusion criteria; * Non-vegetarian diet; * Excessive alcohol and/or drug abuse; * Significant allergies or intolerances concerning the study products; * Participation in another biomedical study within 1 month before the first study visit, possibly interfering with the study results; * Medication use known to hamper subject's safety during the study procedures; * Subjects with contra-indications for MRI and/or PET-CT; * Subjects who do not want to be informed about unexpected medical findings; * Subjects who do not want that their treating physician to be informed; * Co-morbidities to which the intervention or program that may pose as a complicating factor; * Inability to participate and/or complete the required measurements; * PET-CT scan in the last 12 months.

Design outcomes

Primary

MeasureTime frameDescription
Brown adipose tissue activation through 18F-FDG PET-MRIDay 10 of protocolStandard Uptake Value (SUV)

Secondary

MeasureTime frameDescription
Diet-induced thermogenesis through indirect calorimetryDay 8 of protocolWhole body energy expenditure in kJ/kg/min
Posphocreatine (PCr) Recovery through 31P-MRSDay 9 of protocolHalftime of PCr Recovery

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026